Answers are grounded in this paper and cite their sources.
Cross-sectional study reveals high prevalence of depression, anxiety, and stress in adults with type 2 diabetes in Chile, implying urgent need for mental health support.
According to estimates by the International Diabetes Federation (IDF), 589 million adults aged 20-79 years worldwide (11.1%) had diabetes mellitus (DM) in 2024 (1) . Chile exhibited the second-highest prevalence of DM in South America, with 13.0% of the population affected (1) . One risk factor affecting the management and prognosis of type 2 diabetes mellitus (T2DM) is the presence of mental health difficulties (2) . A study estimated that, in 2025, 13.0% of the Chilean population experienced depression symptoms, and 25.8% anxiety (3) , while the prevalence of stress symptoms in the post-pandemic period was 57.0% (4) . Nonetheless, little information is available regarding mental health in individuals with T2DM in this region. The objective of this study was to determine the prevalence of depression, stress, and anxiety symptoms in subjects with T2DM from Copiapo (Chile). A cross-sectional study was conducted in 116 T2DM patients, between 30-65 years old, from the CODIACO cohort. Pregnant or lactating women, as well as subjects with diabetic neuropathy or nephropathy, cancer, or severe inflammatory or infectious diseases, were excluded from the study. Depression, stress, and anxiety levels were measured using the Chile-validated DASS-21 questionnaire (5) . Each domain was classified into five severity levels: normal, mild, moderate, severe, or extremely severe. The results are shown as percentages or medians with interquartile ranges and were analysed using standard statistical methods. Data were analysed using SPSS software. The Scientific Research Ethics Committee of the University of Atacama approved this investigation. The project has been funded by FONDECYT 11180794 and DIUDA 88231R13. The sample included 74 women (63.8%) and 42 men (36.2%), with a median age of 59 (51.5 - 63.0) years. The prevalence of depressive symptoms was found to be 37.9% (mild 6.9%, moderate 18.1%, severe, 3.4%, and extremely severe 9.5%); of stress symptoms, 36.2% (mild 9.5%, moderate 12.9%, severe, 7.8%, and extremely severe 6.0%); of anxiety symptoms, 48.3% (mild 11.2%, moderate 11.2%, severe, 11.2%, and extremely severe 14.7%). Severe and extremely severe symptoms of these mental health problems were more common in women across all domains, though the differences were not statistically significant. This study showed that over one-third of individuals with T2DM in Copiapo exhibited depression symptoms, which is almost triple the prevalence of the general Chilean population (13.0%). Furthermore, the prevalence of anxiety symptoms in our study was nearly half of the individuals, twice as much as in the general Chilean population (25.8%). In addition, stress symptoms were observed in over one-third of individuals with T2DM in Copiapo, though this figure is slightly lower than the prevalence observed in Chile following the global COVID-19 pandemic (57.0%). Further studies are required to investigate the reasons behind the elevated prevalence of mental health complications within the diabetic population.
No takes yet. Share an insight, caveat, or question.
Rojas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: